Tipepidine extends median lifespan in Caenorhabditis elegans

Mitsunari Nakajima1, Ren Shimizu1, Atsushi Sawamoto1

  • 1Department of Pharmaceutical Pharmacology, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime 790-8578, Japan.

Insights

The antitussive drug tipepidine (TIP) extends lifespan in C. elegans by activating AMP-activated protein kinase (AMPK). This anti-aging effect was confirmed in a study using AMPK-deficient mutants.

Area of Science:

  • Gerontology
  • Molecular Biology
  • Pharmacology

Background:

  • Scientists are actively researching anti-aging interventions and medicines.
  • Previous studies indicated tipepidine (TIP) activates AMP-activated protein kinase (AMPK) and improves glucose metabolism.
  • AMPK activation is linked to lifespan extension in model organisms.

Purpose of the Study:

  • To investigate if TIP extends lifespan in Caenorhabditis elegans (C. elegans).
  • To determine if the lifespan-extending effects of TIP are dependent on AMPK activation.

Main Methods:

  • Treatment of wild-type C. elegans (N2) and aak-2(rr48) mutant strains with TIP (50-100 μM).
  • Assessment of median lifespan in treated and control groups.
  • Comparison of lifespan extension between wild-type and mutant strains.

Main Results:

  • TIP treatment significantly extended the median lifespan of wild-type C. elegans.
  • TIP did not extend the median lifespan of the AMPK catalytic subunit mutant aak-2(rr48).

Conclusions:

  • Tipepidine (TIP) demonstrates anti-aging properties by extending lifespan in C. elegans.
  • The lifespan-extending mechanism of TIP is dependent on the activation of AMP-activated protein kinase (AMPK).

Related Concept Videos